AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 146 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $423,329 | +4.8% | 66,666 | 0.0% | 0.32% | -2.1% |
| Q1 2024 | $403,996 | -0.2% | 66,666 | 0.0% | 0.33% | -7.1% |
| Q4 2023 | $404,663 | +43.8% | 66,666 | 0.0% | 0.35% | +28.7% |
| Q3 2023 | $281,331 | +3.5% | 66,666 | -24.0% | 0.28% | +9.1% |
| Q2 2023 | $271,765 | +123.0% | 87,666 | 0.0% | 0.25% | +123.0% |
| Q1 2023 | $121,856 | -30.2% | 87,666 | 0.0% | 0.11% | -34.3% |
| Q4 2022 | $174,455 | -1.4% | 87,666 | 0.0% | 0.17% | -11.8% |
| Q3 2022 | $177,000 | -36.6% | 87,666 | 0.0% | 0.20% | -31.8% |
| Q2 2022 | $279,000 | -23.8% | 87,666 | 0.0% | 0.29% | -8.3% |
| Q1 2022 | $366,000 | -12.9% | 87,666 | 0.0% | 0.31% | -12.4% |
| Q4 2021 | $420,000 | -10.3% | 87,666 | 0.0% | 0.36% | -16.0% |
| Q3 2021 | $468,000 | +4.2% | 87,666 | 0.0% | 0.42% | +3.9% |
| Q2 2021 | $449,000 | -23.9% | 87,666 | 0.0% | 0.41% | -27.9% |
| Q1 2021 | $590,000 | +47.1% | 87,666 | 0.0% | 0.57% | +41.1% |
| Q4 2020 | $401,000 | – | 87,666 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
| BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
| HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
| GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
| Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
| TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
| Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |